Coronary heart disease
Enzymatic estimation of myocardial infarct size when early creatine kinase values are not available

https://doi.org/10.1016/0002-9149(83)90301-6Get rights and content

Abstract

Estimates of myocardial infarct (MI) size based on plasma creatine kinase (CK) are used widely for prognosis and in the assessment of therapy designed to salvage ischemic myocardium. However, if the initial plasma CK activity is elevated, MI size will be underestimated. To determine the impact of loss of early CK values on estimates of Ml size and to develop a procedure to compensate for it, estimates of MI size based on complete and incomplete MB and total CK time-activity curves from 120 patients (experimental group) were compared. Estimates of MI size based on data inclusion intervals beginning at 24,12, 8, and 4 hours before peak CK were 11, 14, 23, and 47% smaller than values based on complete CK curves, but the correlation was good between complete and incomplete estimates of MI size at any given interval, with r values ranging from 0.91 to 0.98. The derived correction factors were then prospectively applied to a new population (n = 25) with complete CK curves to compensate for purposely omitted early CK values. The corrected estimates of MI size were within 7% of those based on the complete CK curves. Similar results were obtained for transmural and nontransmural and anterior or inferior MI. Thus, if peak plasma CK is known, underestimation of MI size can be compensated for despite the unavailability of early CK values. Since > 90% of patients present before plasma CK has reached its peak (24 hours), Ml size can be obtained in nearly all patients. Thus, being able to correct for unavailable early CK values makes MI size a more widely applicable endpoint for use in clinical trials and patient management.

References (30)

  • A Hjalmarson et al.

    The effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial

    Lancet

    (1981)
  • WE Shell et al.

    Protection of jeopardized ischemic myocardium by reduction of ventricular afterload

    N Engl J Med

    (1974)
  • R Roberts et al.

    Deleterious effects of methylprednisone in patients with myocardial infarction

    Circulation

    (1976)
  • T Peter et al.

    Reduction of enzyme levels after acute myocardial infarction by propranolol

    Circulation

    (1978)
  • JD Durrer et al.

    Effect of sodium nitroprusside on mortality in acute myocardial infarction

    N Engl J Med

    (1982)
  • JN Conn et al.

    Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration Cooperative Study

    N Engl J Med

    (1982)
  • R Roberts et al.

    Nifedipine and acute myocardial infarction

    Herz

    (1981)
  • J Morrison et al.

    Modification of myocardial injury in man by corticosteroid administration

    Circulation

    (1976)
  • Y Varonkov et al.

    Augmentation of serum CPK activity by digitalis in patients with acute myocardial infarction

    Circulation

    (1977)
  • MD Bussmann et al.

    Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin

    Circulation

    (1981)
  • JA Cairns et al.

    Intravenous hyaluronidase therapy for myocardial infarction in man: double-blind trial to assess infarct size limitation

    Circulation

    (1982)
  • BE Sobel et al.

    Estimation of infarct size in man and its relation to prognosis

    Circulation

    (1972)
  • KM Geltman et al.

    The influence of location and extent of myocardial infarction on longterm ventricular dysrhythmia and mortality

    Circulation

    (1979)
  • JA Cairns

    Assessment of acute myocardial infarction in humans by serial CPK technique

    Royal Col Phys Surg Can

    (1978)
  • W Bleifeld et al.

    Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics

    Circulation

    (1977)
  • Cited by (19)

    • The quantification of infarct size

      2004, Journal of the American College of Cardiology
      Citation Excerpt :

      Peak CK-MB can be used as a substitute for the area under the curve if one has a sufficient number of samples to detect true peak values. Smith et al. (13) found that the degree of underestimation of infarct size ranged from 14% to 47% when the data from the upslope of the CK-MB time activity curves were missing. The correlations were good for both Q-wave and non–Q-wave MI when peak values were ascertained (13).

    • Troponin, where do we go from here?

      1997, Clinics in Laboratory Medicine
    View all citing articles on Scopus

    This study was supported in part by the Multicentered Investigation for Limitation of Infarct Size (MILIS), Contract NOL-HV-72941 from the National Institutes of Health, Bethesda, Maryland.

    View full text